Chemclin Diagnostics Co., Ltd. Stock
Equities
688468
CNE100005311
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.95 CNY | +1.40% | +7.00% | -26.32% |
May. 03 | Chemclin Diagnostics Launches Homegrown Immunodetection Kits | MT |
Apr. 29 | Chemclin Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 465M 64.4M | Sales 2023 | 445M 61.64M | Capitalization | 4.33B 599M |
---|---|---|---|---|---|
Net income 2022 | 153M 21.18M | Net income 2023 | 147M 20.35M | EV / Sales 2022 | 6.07 x |
Net cash position 2022 | 973M 135M | Net cash position 2023 | 684M 94.69M | EV / Sales 2023 | 8.18 x |
P/E ratio 2022 |
24.9
x | P/E ratio 2023 |
29.2
x | Employees | 690 |
Yield 2022 |
3.66% | Yield 2023 |
-
| Free-Float | 38.85% |
1 day | +1.40% | ||
1 week | +7.00% | ||
Current month | +7.00% | ||
1 month | +9.96% | ||
3 months | +11.19% | ||
6 months | -30.26% | ||
Current year | -26.32% |
Managers | Title | Age | Since |
---|---|---|---|
Lin Li
CEO | Chief Executive Officer | 62 | 07-12-31 |
Yan Ling Huang
DFI | Director of Finance/CFO | 49 | 07-12-31 |
Hong Yan Pu
BRD | Director/Board Member | 50 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Jie Zhang
BRD | Director/Board Member | 47 | 19-09-10 |
Jie Zhang
BRD | Director/Board Member | 71 | 19-10-23 |
Lin Li
CEO | Chief Executive Officer | 62 | 07-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 7.95 | +1.40% | 4,021,255 |
24-05-08 | 7.84 | -0.51% | 3,484,409 |
24-05-07 | 7.88 | -0.25% | 4,128,281 |
24-05-06 | 7.9 | +6.33% | 6,980,163 |
End-of-day quote Shanghai S.E., May 08, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-26.32% | 442M | |
0.00% | 12.64B | |
-1.64% | 8.37B | |
+0.45% | 5.37B | |
+22.42% | 5.26B | |
-0.09% | 4.58B | |
-52.84% | 3.16B | |
+20.02% | 2.89B | |
-8.37% | 2.22B | |
-2.45% | 1.91B |
- Stock Market
- Equities
- 688468 Stock